Does Medicaid Cover Prescription Drugs? (2026)

Direct Answer: Yes, Medicaid Covers Prescription Drugs in All 50 States

Yes. Every state Medicaid program covers outpatient prescription drugs in 2026. Prescription drug coverage is technically optional under the federal Social Security Act, but all 50 states have elected it because the Medicaid Drug Rebate Program (MDRP) allows states to pay far below market price. Under ACA rules, prescription drugs are an Essential Health Benefit that Medicaid expansion plans must cover in full. Federal rules require drug manufacturers to enter a national rebate agreement with CMS before their drugs can be covered; in exchange, states must cover nearly all FDA-approved drugs from those manufacturers. This near-open formulary means Medicaid generally covers a broader range of drugs than many private insurance plans.

How the Medicaid Drug Rebate Program Works (and Why It Matters to You)

The Medicaid Drug Rebate Program (MDRP), established by Congress in 1990, is the mechanism behind Medicaid's broad drug coverage. Drug manufacturers that want Medicaid to cover their products must sign a national rebate agreement with CMS. The federal rebate floor for a brand-name drug is the greater of 23.1% of the drug's average manufacturer price (AMP) or the difference between AMP and the best price the manufacturer has offered any other buyer. Generic drugs carry a 13% AMP rebate floor.

As of 2025, 48 states plus DC also negotiate supplemental rebates beyond the federal floor, reducing state drug costs further. Because manufacturers must enter the MDRP to have any Medicaid coverage, Medicaid's formulary spans nearly every major drug class. The small categories states may lawfully exclude without a waiver include drugs used solely for weight loss, fertility treatments, cosmetic purposes, and cough and cold remedies, though many states cover some of these anyway.

Preferred Drug Lists and Prior Authorization: What They Mean for Your Prescriptions

While Medicaid must cover nearly all rebating drugs, states control which drugs they prefer through Preferred Drug Lists (PDLs). A PDL ranks drugs in the same therapeutic class, placing some on a preferred tier (lower cost to the state, sometimes lower copay to you) and others on a non-preferred tier. When a prescriber writes for a non-preferred drug, the state may require prior authorization (PA) before the pharmacy will fill it. Prior auth means your doctor must submit documentation to your Medicaid plan showing why the preferred alternative would not work for your condition.

Step therapy is a related tool: the plan requires you to try a lower-cost drug first and demonstrate it failed before covering the higher-cost option. Quantity limits restrict how much of a drug can be dispensed in a given time period. States and managed care plans must have an exceptions process that allows a prescriber to get authorization for a non-preferred or step-therapy drug when there is a documented clinical reason. Under federal Medicaid managed care rules finalized in 2024, plans must respond to standard prior auth requests within 14 days and urgent requests within 72 hours.

Medicaid Prescription Drug Copays in 2026

Federal regulations under 42 CFR 447.54 cap what Medicaid programs can charge enrollees for prescription drugs. For enrollees with income at or below 150% of the 2026 federal poverty level ($23,940 for an individual), copays are limited to nominal amounts: $4 for preferred drugs and $8 for non-preferred drugs per prescription. These nominal limits are adjusted annually using the medical care component of the Consumer Price Index. States may choose to charge no copay at all, and many do for the lowest-income enrollees.

Certain enrollees are fully exempt from prescription drug copays regardless of income: pregnant women, children under 18, emergency services recipients, and institutionalized individuals. Medicaid managed care plans follow the same federal copay caps; they cannot charge more than fee-for-service Medicaid for prescription drugs. If you are dual-eligible (both Medicare and Medicaid), Medicare Part D is primary and Medicaid wraps around to cover the Part D copays, so dual-eligible enrollees effectively pay $0 or near $0 for most medications through the Part D Extra Help (Low-Income Subsidy) program.

What Medicaid Covers by Drug Category in 2026

Medicaid covers a wide range of drug categories in 2026. Chronic disease medications including medications for diabetes, heart disease, high blood pressure, asthma, and mental health conditions are covered in all states. Medications for opioid use disorder (MAT), including methadone, buprenorphine, and naltrexone, must be covered in all states under the ongoing requirements from the SUPPORT for Patients and Communities Act. HIV antiretroviral therapy and hepatitis C direct-acting antivirals are covered in all states, though some states still impose prior auth for hepatitis C drugs. Insulin is covered in all states with no special exclusion, and Medicaid enrollees pay the capped copay amounts.

GLP-1 receptor agonists (semaglutide, tirzepatide) for type 2 diabetes are covered in all states when prescribed for diabetes management. Coverage for weight-loss use of GLP-1 drugs is more variable: the federal exclusion allows states to deny them for obesity treatment without a waiver, but a growing number of states have added coverage or obtained waivers. As of early 2026, roughly a dozen states cover GLP-1s for obesity under Medicaid, and CMS has been actively encouraging broader coverage. Specialty drugs for conditions like rheumatoid arthritis, multiple sclerosis, and cancer are covered with prior authorization in most states.

What Medicaid Does Not Cover for Prescription Drugs

Federal law allows states to exclude several drug categories without a waiver. The most common lawful exclusions are: drugs used solely for weight loss or weight gain (unless a state has obtained a waiver); drugs used for fertility treatment; drugs used for cosmetic purposes or hair growth; cough and cold products; and prescription vitamins and minerals other than prenatal vitamins. States may also exclude barbiturates and benzodiazepines from Medicaid managed care drug benefits (though most states cover them).

Over-the-counter (OTC) drugs are generally not covered unless a physician writes a prescription for them and the state's PDL includes them as covered. Compounded drugs require case-by-case review: states may cover compounded medications that are medically necessary and not available in a commercially manufactured equivalent, but coverage is not automatic. Brand-name drugs for which a generic equivalent exists may be subject to step therapy requiring the generic first, even if the generic is on the PDL.

What To Do If Medicaid Denies Your Prescription

Medicaid prescription denials fall into two main types: a pharmacy-level rejection (the drug is not on the formulary or requires prior auth, and the claim was rejected at the point of sale) and a formal coverage denial (the plan reviewed a prior auth request and denied it). For a pharmacy-level rejection, the first step is to ask the pharmacist why the claim was rejected and whether a preferred alternative exists. If a preferred alternative is clinically inappropriate, your doctor can submit a prior authorization request or a step therapy exception request with documentation of why the standard alternative is not suitable for you.

For a formal denial, Medicaid enrollees have the right to appeal. The plan must issue a written denial stating the specific reason. You have the right to file an internal appeal within the plan's timeframe (typically 60 days), request continuation of the current prescription if you were already receiving it during the appeal, and request a state fair hearing if the internal appeal fails. Under federal managed care rules effective 2024, expedited appeals for urgent drug needs must be resolved within 72 hours. The National Health Law Program (healthlaw.org) publishes free state-by-state Medicaid appeal guides.

Alternatives When Medicaid Does Not Cover a Specific Drug

When prior authorization is denied or a specific drug falls outside Medicaid coverage, several alternatives exist. First, ask your prescriber if a preferred-tier alternative in the same drug class would work equally well for your condition. Second, manufacturer patient assistance programs (PAPs) offer free or reduced-cost drugs to low-income uninsured or underinsured individuals; most major drug manufacturers have PAPs and eligibility is often broader than many people expect. NeedyMeds.org maintains a comprehensive database of PAPs searchable by drug name.

Third, pharmacy discount programs such as GoodRx, RxSaver, and the state-run programs in several states may reduce the cash price of a drug below the Medicaid copay amount. Fourth, federally qualified health centers (FQHCs) purchase drugs through the 340B Drug Pricing Program, which allows them to dispense medications at significantly below-market prices to eligible patients. Fifth, if you are also covered by Medicare (dual-eligible), the Medicare Part D Extra Help program may cover the drug even if Medicaid does not, since Part D has its own formulary. Check Medicare.gov/plan-compare to find a Part D plan covering your drug.

Dual-Eligible Enrollees: How Medicare Part D and Medicaid Work Together

About 12 million Americans are dual-eligible for both Medicare and Medicaid in 2026. For prescription drugs, Medicare is the primary payer and Medicaid acts as a secondary wrap-around. All dual-eligible individuals qualify for the Part D Low-Income Subsidy (LIS), also called Extra Help, which in 2026 means generic drugs cost $4.90 and brand-name drugs cost $12.15 per fill at standard copay levels. Full-benefit dual-eligible individuals (qualifying for full Medicaid benefits) pay $0 in copays for Part D drugs if their income is at or below 100% of the 2026 federal poverty level.

Dual-eligible individuals are automatically enrolled in a Medicare Dual Eligible Special Needs Plan (D-SNP) or can choose their own Part D plan. Medicaid covers the Part D premium and cost-sharing for full-benefit dual-eligibles, effectively making drug coverage free or near-free. If a drug is covered by Medicaid but not Part D, Medicaid can pay after Medicare denies. One common gap: certain state Medicaid programs cover drugs in categories excluded from Part D (such as benzodiazepines or barbiturates), so dual-eligibles may be able to access those through the Medicaid fee-for-service benefit.

Does Medicaid cover prescription drugs in all 50 states in 2026?

Yes. All 50 state Medicaid programs cover outpatient prescription drugs in 2026. Prescription drug coverage is technically an optional benefit under the federal Social Security Act, but every state has elected it. Federal rules under the Medicaid Drug Rebate Program (MDRP) require states to cover nearly all FDA-approved drugs from manufacturers that participate in the rebate program, creating a near-open formulary broader than most private insurance plans.

What is a Preferred Drug List (PDL) and how does it affect my Medicaid coverage?

A Preferred Drug List (PDL) is your state's ranking of drugs within the same therapeutic category. Preferred-tier drugs are covered at a lower copay ($4 in 2026) with no prior authorization required. Non-preferred drugs cost more ($8 copay) and usually need prior authorization. If your prescribed drug is non-preferred, your doctor can submit a prior auth request with documentation explaining why the preferred alternative is not appropriate for your condition. All 50 states maintain PDLs, though the specific drugs on each tier vary by state.

How much do prescription drug copays cost under Medicaid in 2026?

Federal regulations cap Medicaid prescription copays at $4 for preferred drugs and $8 for non-preferred drugs per fill for enrollees with income at or below 150% of the federal poverty level ($23,940 for a single person in 2026). Children under 18, pregnant women, and institutionalized enrollees are fully exempt from copays. Many states charge lower copays or no copay at all for the lowest-income enrollees. Dual-eligible individuals on both Medicare and Medicaid generally pay $0 through the Part D Extra Help program.

Does Medicaid cover insulin?

Yes. Medicaid covers insulin in all 50 states. Insulin falls within the diabetic medication category, which is not among the limited drug classes states may exclude. Medicaid enrollees pay the standard copay cap ($4 preferred / $8 non-preferred) for insulin prescriptions. For dual-eligible individuals, Medicare Part D covers insulin with a $35 per-month per-drug cap for Part D-covered insulin types under the Inflation Reduction Act, signed August 16, 2022.

Does Medicaid cover GLP-1 drugs like Ozempic or Wegovy?

It depends on the indication. Medicaid covers GLP-1 receptor agonists (semaglutide, tirzepatide) when prescribed for type 2 diabetes management in all states, subject to PDL placement and possible prior auth. Coverage for GLP-1 drugs prescribed solely for weight loss or obesity is more variable. Federal law allows states to exclude weight-loss drugs without a waiver, but roughly a dozen states have added GLP-1 obesity coverage or obtained Section 1115 waivers as of early 2026. Ask your prescriber to write the diabetes-management indication on the prescription if you have type 2 diabetes.

What can I do if Medicaid denies my prescription?

First, ask the pharmacist why it was rejected: it may be a PDL tier issue (easy fix with a preferred alternative), a prior auth requirement (your doctor can submit), or a step therapy issue (try the step-one drug first, or document why you cannot). If a formal prior auth is denied, Medicaid must give you a written denial with the reason. You have the right to appeal within 60 days, request a state fair hearing if the appeal fails, and ask for continuation of the drug during the appeal if you were already receiving it. Expedited appeals for urgent needs must be resolved within 72 hours under federal managed care rules.

Does Medicaid cover specialty drugs for conditions like MS, rheumatoid arthritis, or cancer?

Yes, with prior authorization in most states. Specialty drugs for conditions like multiple sclerosis, rheumatoid arthritis, HIV, hepatitis C, and many cancers are covered under Medicaid's near-open formulary because their manufacturers participate in the MDRP. Nearly all states require prior authorization for specialty drugs given their high cost. Step therapy is also common, requiring you to try a less expensive agent first. ACA Medicaid expansion plans additionally prohibit annual or lifetime dollar caps on any covered drug, including specialties.

If I have both Medicare and Medicaid (dual-eligible), which covers my prescriptions?

Medicare Part D is primary for prescription drugs when you are dual-eligible. All dual-eligible individuals automatically qualify for Part D Extra Help (Low-Income Subsidy), which in 2026 caps drug costs at $4.90 for generics and $12.15 for brand-name drugs per fill. Full-benefit dual-eligible individuals with income at or below 100% of the 2026 federal poverty level pay $0 copay. Medicaid covers the Part D premium and any remaining cost-sharing. If a drug is covered by Medicaid but not Part D (such as some benzodiazepines), Medicaid may pay after Medicare denies.